Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-06-11 Sale | 2024-06-11 8:56 pm | Deciphera Pharmaceuticals Inc. | Kelly Thomas Patrick Chief Financial Officer | 72,029 | $0 | $0 | 0 (Direct) | View | |
| 2024-02-16 Sale | 2024-02-20 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 3,010 | $15.62 | $47,009 | 149,450 (Direct) | View |
| 2024-01-16 Sale | 2024-01-18 4:15 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 2,435 | $14.47 | $35,234 | 66,085 (Direct) | View |
| 2023-12-13 Sale | 2023-12-14 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 2,792 | $15.37 | $42,905 | 68,520 (Direct) | View |
| 2023-10-30 Sale | 2023-10-31 4:09 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 2,316 | $12.02 | $27,833 | 63,068 (Direct) | View |
| 2023-06-16 Sale | 2023-06-21 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 1,655 | $14.4 | $23,835 | 57,140 (Direct) | View |
| 2023-02-16 Sale | 2023-02-17 4:09 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 1,370 | $15.1 | $20,686 | 124,695 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 2,403 | $21.24 | $51,043 | 43,677 (Direct) | View |
| 2022-06-16 Sale | 2022-06-21 4:35 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 1,768 | $10.75 | $19,006 | 46,080 (Direct) | View |
| 2022-02-16 Sale | 2022-02-18 5:01 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 1,368 | $9.05 | $12,380 | 47,848 (Direct) | View |
| 2021-02-16 Sale | 2021-02-18 7:00 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 524 | $48.87 | $25,608 | 67,516 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-10-15 Option Award | 2025-10-17 6:43 pm | N/A 2035-10-14 | Xenon Pharmaceuticals Inc. | XENE | Kelly Thomas Patrick Chief Financial Officer | 255,000 | $0 | 255,000 (Direct) | View |
Ownership | 2025-10-17 6:41 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | Kelly Thomas Patrick Chief Financial Officer | 0 | $0 | 0 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-11 8:56 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | Kelly Thomas Patrick Chief Financial Officer | 34,157 | $0 | 0 (Direct) | View | |
| 2024-06-11 Equity Swap | 2024-06-11 8:56 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | Kelly Thomas Patrick Chief Financial Officer | 42,478 | $0 | 0 (Direct) | View | |
| 2024-02-15 Option Award | 2024-02-20 4:05 pm | N/A 2034-02-14 | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 86,375 | $0 | 149,450 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 4:05 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 8,244 | $0 | 68,520 (Direct) | View |
| 2023-10-28 Option Award | 2023-10-31 4:09 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 8,244 | $0 | 63,068 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 4:09 pm | N/A 2033-02-14 | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 82,388 | $0 | 124,695 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:00 pm | N/A 2032-01-17 | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 102,500 | $0 | 131,216 (Direct) | View |
| 2021-12-15 Option Award | 2021-12-17 4:10 pm | N/A 2031-12-14 | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 93,365 | $0 | 110,981 (Direct) | View |
| 2021-02-16 Option Award | 2021-02-18 7:00 pm | N/A 2031-02-15 | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 61,000 | $0 | 67,516 (Direct) | View |